• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

  • Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • Countering AMR
  • COVID-19 Research
  • Digital Therapies
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

OHE Innovation Policy Prize

  As OHE’s Chief Executive, I am writing on behalf of our Board of Trustees and the entire OHE research team to announce the launch of the inaugural biennial OHE Innovation Policy Prize of £40,000. This year, OHE is celebrating…

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for PolicymakersRead more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes
  • PhRMA

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
When Generic Measures Fail to Reflect What Matters to Patients: Three Case StudiesRead more
© NCI/Unsplash
  • Health Technology Assessment…
  • Measuring and Valuing Outcomes
  • Canada

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Cancer_WellcomeCollection_landscape
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic TherapiesRead more
© WellcomeCollection
Close
OHE
  • All Publications

    Filter by:
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • Countering AMR
    • COVID-19 Research
    • Digital Therapies
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 18th May 2022

OHE Innovation Policy Prize

  As OHE’s Chief Executive, I am writing on behalf of our Board of Trustees and the entire OHE research team to announce the launch of the inaugural biennial OHE Innovation Policy Prize of £40,000. This year, OHE is celebrating…

Tim 3
Tim Watson
Share:
Prize-hub-banner_1

 

As OHE’s Chief Executive, I am writing on behalf of our Board of Trustees and the entire OHE research team to announce the launch of the inaugural biennial OHE Innovation Policy Prize of £40,000.

This year, OHE is celebrating our 60th anniversary, making it one of the oldest health economics research organisations globally. OHE was founded at the birth of health economics and has contributed to the development of novel theory and methodology, shaped the major policy and academic debates, and played a role in ultimately improving health and health care.

A major area of research for OHE has always been the economics of innovation, and OHE has made significant contributions to the development of theory, evidence, and practice in this area. All of which, dating back to 1962, is available on our website for public benefit. For example; The Many Faces of Innovation, Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation and The Lower Drug Costs Now Act and Pharmaceutical Innovation.

There can be no doubt about the huge value that innovation in life sciences delivers for each and every one of us. The record-breaking development of multiple COVID-19 vaccines, potential curative gene therapies for spinal muscular atrophy, or even the antibiotics which enables medicine and surgery to be performed safely.

However, new medicines are not without controversy in particular in the area of pricing and access. Despite significant research on the topic, how to balance the needs of patients, health systems and innovators remains a challenging topic. As economists, we believe that the market has an important role to play in aligning incentives, value, and rewards – that there is a challenging but critical balance between short-term static efficiency and long-term dynamic efficiency.

To mark our 60th anniversary and in support of our charitable goal of improving the quantity and quality of the debate within health economics, we are launching a biennial Innovation Policy Prize. We hope the OHE Prize will be a platform for generating novel ideas and solutions, sharing perspectives across disciplines and countries, as well as encouraging more research into the economics of the life sciences sector.

The question we are posing for our first prize fund year is: “How can policymakers design a system to generate fair prices that balances access and innovation throughout the lifecycle of medicines?”.

Entry is free of charge and open to everyone without an affiliation to OHE (Prize terms and conditions). Please visit the OHE Innovation Policy Prize website for further information on how to enter the competition including an Author’s Guidance Pack designed to help entrants have the best chance of success.

We encourage you to share your ideas on how to address this challenging problem for the chance to win a £40,000 prize.

Good luck!

Graham Cookson
Chief Executive, OHE

  • 60th Anniversary

Related News

MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 OHE

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!